NxStage Medical (NASDAQ:NXTM) is a medical device company in the dialysis therapy market that develops, manufactures and markets innovative products for the treatment of kidney failure, fluid overload and related blood treatments and procedures. It is a smaller company in the market compared to established players, such as Fresenius (NYSE:FMS) and DaVita (NYSE:DVA). These two companies account for more than half of the conventional dialysis market segment in the United States. However, NxStage Medical's System One is currently the only portable system specifically indicated for use in the home hemodialysis market segment in the United States.
NXTM debuted in the stock market in late 2005. In 2011 NXTM crossed $25 before witnessing a secular...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|
|PRO Top long ideas returned 21.7% in 2016**|